Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses

Claudia Brodskyn1, Julie Patricio, Rubem Oliveira

  • 1Centro de Pesquisa Gonçalo Moniz, FIOCRUZ, Instituto de Ciências da Saúde, Universidade Federal Bahia, Salvador, Brazil.

Insights

Trypanosoma cruzi glycoinositolphospholipid (GIPL) suppresses immune cells like macrophages and dendritic cells (DC). This immune modulation by GIPL may help the parasite evade the host immune response, contributing to disease pathogenesis.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Antigen-presenting cells (APCs), including macrophages and dendritic cells (DCs), are crucial for initiating adaptive immune responses.
  • Trypanosoma cruzi, the causative agent of Chagas disease, employs various strategies to evade host immunity.
  • Glycoinositolphospholipids (GIPLs) are major surface molecules of Trypanosoma cruzi with potential immunomodulatory functions.

Purpose of the Study:

  • To investigate the immunomodulatory effects of Trypanosoma cruzi GIPL on human macrophages and dendritic cells (DCs).
  • To determine the impact of GIPL on the production of key cytokines and the expression of surface markers involved in immune activation.

Main Methods:

  • Human macrophages and DCs were stimulated with lipopolysaccharide (LPS) in the presence or absence of T. cruzi GIPL.
  • Cytokine levels (TNF-alpha, IL-8, IL-10, IL-12p40) in cell supernatants were measured using ELISA.
  • Surface expression of immune markers (CD80, CD86, HLA-DR, CD40, CD57, CD83) was analyzed by flow cytometry.

Main Results:

  • T. cruzi GIPL significantly decreased the secretion of TNF-alpha, IL-10, and IL-12p40 by both macrophages and DCs stimulated with LPS.
  • GIPL down-regulated the expression of multiple surface molecules (CD80, CD86, HLA-DR, CD40, CD57) on macrophages and (HLA-DR, CD83, CD86, CD80, CD40) on DCs.
  • The ceramide portion of GIPL was identified as the primary active component responsible for these immunomodulatory effects.

Conclusions:

  • Trypanosoma cruzi GIPL exhibits potent immunosuppressive activities on human antigen-presenting cells.
  • These immunoregulatory effects, particularly the inhibition of cytokine production and surface marker expression, likely contribute to parasite evasion of the host immune system.
  • The findings suggest that T. cruzi GIPL plays a significant role in the pathogenesis of Chagas disease by dampening critical immune responses.